Related Experiment Video
Updated: Jun 24, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Challenges in cancer research and multifaceted approaches for cancer biomarker quest
Jirina Martinkova1, Suresh Jivan Gadher, Marian Hajduch
1Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, v.v.i., Rumburska 89, 27721 Libechov, Czech Republic.
Abstract:
Recent advances in cancer biology have subsequently led to the development of new molecularly targeted anti-cancer agents that can effectively hit cancer-related proteins and pathways. Despite better insight into genomic aberrations and diversity of cancer phenotypes, it is apparent that proteomics too deserves attention in cancer research. Currently, a wide range of proteomic technologies are being used in quest for new cancer biomarkers with effective use. These, together with newer technologies such as multiplex assays could significantly contribute to the discovery and development of selective and specific cancer biomarkers with diagnostic or prognostic values for monitoring the disease state. This review attempts to illustrate recent advances in the field of cancer biomarkers and multifaceted approaches undertaken in combating cancer.
Insights
Cancer research is advancing with molecularly targeted therapies and proteomic technologies. These innovations aid in discovering novel cancer biomarkers for improved diagnostics and prognostics.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Cancer biology advances drive development of targeted anti-cancer agents.
- Genomic insights reveal cancer phenotype diversity, highlighting proteomics' importance.
- Proteomic technologies are crucial for identifying new cancer biomarkers.
Purpose of the Study:
- To review recent advancements in cancer biomarkers.
- To illustrate multifaceted approaches in cancer research and treatment.
- To highlight the role of proteomics in cancer biomarker discovery.
Main Methods:
- Review of current proteomic technologies used in cancer research.
- Exploration of newer technologies like multiplex assays.
- Analysis of diagnostic and prognostic biomarker applications.
Main Results:
- Molecularly targeted agents show efficacy against cancer proteins and pathways.
- Proteomics offers significant potential for cancer biomarker identification.
- Multiplex assays and other technologies enhance biomarker discovery.
Conclusions:
- Proteomics is essential for comprehensive cancer research.
- Advanced technologies facilitate the development of specific cancer biomarkers.
- Biomarkers are key for monitoring disease state and improving cancer management.
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...